Skip to main content
. 2020 May 15;11:797. doi: 10.3389/fmicb.2020.00797

TABLE 2.

Antimicrobial resistance phenotype and genotype of the macrolide and lincosamide resistant β-hemolytic streptococcal isolates.

Microbe n Phenotype (n) Genotype (n)
S. pyogenes 15 iMLSB (1) erm(A) (1)
cMLSB (14) erm(B) (14)
M (0)
L (0)
Tet R (14) tet(M) (14)
S. agalactiae 53 iMLSB (7) erm(A) (6), erm(T) (1)
cMLSB (38) erm(A) (8), erm(B) (26), erm(B) + lsa(C) (2), erm(B) + lsa(E) + lnu(B) (1), ND (1)
M (6) mef(A) (6)
L (2) lsa(C) (2)
Tet R (50) tet(M) (31), tet(O) (17), tet(M) + tet(O) (2)
S. dysgalactiae 19 iMLSB (11) erm(A) (11)
cMLSB (6) erm(A) (3), erm(B) (3)
M (1) mef(A) (1)
L (1) lsa(C) (1)
Tet R (6) tet(M) (4), tet(O) (1), tet(M) + tet(O) (1)

n, number of isolates; MLSB, macrolide, lincosamide, streptogramin B; iMLSB, inducible MLSB-resistance; cMLSB, constitutive MLSB-resistance, M, macrolide resistance alone; L, lincosamide resistance alone; Tet R, tetracycline resistance; ND, no resistance gene detected.